Protein-energy malnutrition

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Protein-energy malnutrition is curable or preventable in most cases when therapeutic foods and medical care are available. Access gaps persist, but the overall trajectory is encouraging: deaths have been falling steadily over recent decades. No landmark milestone yet marks the field; progress has come from spreading proven nutrition programs and food security efforts. Clinical research remains modest—five trials began in the past five years, none in phase 3, with six active studies.

Is protein-energy malnutrition really curable?

Yes, for most children when treated early with therapeutic foods and supportive care. It is also preventable through good feeding practices and food security. Worldwide, not every child receives those interventions, so treatment access remains uneven.

Are deaths from this condition going up or down?

Over recent decades, deaths have been falling steadily. This is well established across global nutrition data. Progress has come from improved food security, breastfeeding support, and therapeutic feeding programs, though large gaps remain in some regions.

What does current research on malnutrition look like?

Research is relatively limited right now. Over the last five years, five trials started, but none has reached phase 3. Six trials are currently active, mostly focused on improving treatment delivery and long-term outcomes.

Are there any major breakthroughs expected soon?

No landmark milestone is listed for this field. With no phase-three trials underway, dramatic new cures are unlikely soon. Researchers are more likely to refine existing treatments and prevention programs than introduce a single breakthrough.